Abstract
Background: Oral isotretinoin has been used to treat mild to severe hidradenitis suppurativa (HS). Objective: We reviewed the results of low-dose isotretinoin for 4 to 6 months in the treatment of 68 patients with HS. Methods: This is a retrospective study. Data are presented in terms of response rate, long-term follow-up, and the relation between response rate and severity. Results: In 16 patients (23.5%), the condition completely cleared during initial therapy and 11 patients (16.2%) maintained their improvement during the follow-up period. Treatment was more successful in the milder forms of HS. Conclusion: Monotherapy with isotretinoin for patients with HS usually has a limited therapeutic effect.(J Am Acad Dermatol 1999;40:73-6.)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
